Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A13026 | 30175257 | Anim Nutr | Inhibitory effect of blue honeysuckle extract on high-fat-diet-induced fatty liver in mice. | 2018 | Details |
A13028 | 30174213 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. | 2018 | Details |
A13033 | 30171810 | Horm Mol Biol Clin Investig | Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis. | 2018 | Details |
A13039 | 30170304 | Nutrition | Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial. | 2018 | Details |
A13042 | 30168806 | J Clin Invest | Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease. | 2018 | Details |
A13043 | 30166956 | Gastroenterol Hepatol (N Y) | Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A13044 | 30166861 | World J Gastroenterol | C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. | 2018 | Details |
A13075 | 30149145 | Diabetes Metab | SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes. | 2018 | Details |
A13076 | 30148144 | World J Clin Cases | PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease. | 2018 | Details |
A13079 | 30145577 | Ann Hepatol | Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats. | 2018 | Details |
A13095 | 30140371 | Oxid Med Cell Longev | Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway. | 2018 | Details |
A13100 | 30138985 | Zhonghua Yi Xue Za Zhi | [The expression of chemerin and the influence of sitagliptin on its expression in non-alcoholic fatty liver disease rats complicated with prediabetes]. | 2018 | Details |
A13106 | 30135638 | Cent Eur J Immunol | Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease. | 2018 | Details |
A13107 | 30135414 | Molecules | Modulatory Effect of Polyphenolic Compounds from the Mangrove Tree Rhizophora mangle L. on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in High-Fat Diet Obese Mice. | 2018 | Details |
A13118 | 30131870 | NPJ Syst Biol Appl | Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease. | 2018 | Details |
A13124 | 30128963 | Curr Nutr Rep | Nutritional Ketosis for Weight Management and Reversal of Metabolic Syndrome. | 2018 | Details |
A13127 | 30127768 | Front Endocrinol (Lausanne) | Dietary Protein and Energy Balance in Relation to Obesity and Co-morbidities. | 2018 | Details |
A13131 | 30123057 | Int J Med Sci | Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice. | 2018 | Details |
A13138 | 30120579 | Curr Diab Rep | Emerging Role of AMPK in Brown and Beige Adipose Tissue (BAT): Implications for Obesity, Insulin Resistance, and Type 2 Diabetes. | 2018 | Details |
A13139 | 30120555 | Pflugers Arch | Catalase and nonalcoholic fatty liver disease. | 2018 | Details |
A13147 | 30115876 | Molecules | Hepatoprotective Effects of MHY3200 on High-Fat, Diet-Induced, Non-Alcoholic Fatty Liver Disease in Rats. | 2018 | Details |
A13148 | 30115487 | J Diabetes Complications | Body fat, metabolic syndrome and hyperglycemia in South Asians. | 2018 | Details |
A13149 | 30114411 | Life Sci | C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis. | 2018 | Details |
A13151 | 30113367 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. | 2018 | Details |
A13163 | 30106314 | Climacteric | Association of serum ferritin levels with non-alcoholic fatty liver disease in postmenopausal women. | 2018 | Details |
A13169 | 30103390 | Nutrients | Delphinidin Ameliorates Hepatic Triglyceride Accumulation in Human HepG2 Cells, but Not in Diet-Induced Obese Mice. | 2018 | Details |
A13177 | 30099414 | Wiad Lek | Pathogenesis of insulin resistance in pregnant women with obesity. | 2018 | Details |
A13181 | 30098126 | Diabetes Obes Metab | The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. | 2018 | Details |
A13186 | 30096092 | Eur J Gastroenterol Hepatol | Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot. | 2018 | Details |
A13192 | 30092609 | Obes Rev | The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis. | 2018 | Details |
A13196 | 30090738 | Indian J Endocrinol Metab | Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2020 | Details |
A13197 | 30090726 | Indian J Endocrinol Metab | Neck Circumference to Height Ratio is a Reliable Predictor of Liver Stiffness and Nonalcoholic Fatty Liver Disease in Prediabetes. | 2022 | Details |
A13199 | 30089858 | Lab Invest | Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis. | 2018 | Details |
A13202 | 30087027 | Hepatobiliary Pancreat Dis Int | Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population. | 2018 | Details |
A13203 | 30086995 | Psychosomatics | Cognitive Performance in Individuals With Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus. | 2018 | Details |
A13210 | 30081580 | Nutrients | Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways. | 2018 | Details |
A13230 | 30073766 | Diabetes Obes Metab | Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study. | 2018 | Details |
A13234 | 30071259 | Biochimie | Sphingolipid metabolism in non-alcoholic fatty liver diseases. | 2018 | Details |
A13235 | 30070873 | Nutr Hosp | Vitamin D nutritional status and its relationship with metabolic changes in adolescents and adults with severe obesity. | 2018 | Details |
A13237 | 30070430 | Mol Nutr Food Res | Soyasaponins Reduce Inflammation and Improve Serum Lipid Profiles and Glucose Homeostasis in High Fat Diet-Induced Obese Mice. | 2018 | Details |
A13244 | 30066228 | Infection | Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. | 2018 | Details |
A13251 | 30063751 | PLoS One | Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD. | 2018 | Details |
A13254 | 30063256 | Hepatology | Dual-Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression. | 2018 | Details |
A13256 | 30061575 | Nat Commun | Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis. | 2018 | Details |
A13258 | 30060808 | Adv Cancer Res | Sphingolipids at the Crossroads of NAFLD and Senescence. | 2018 | Details |
A13260 | 30060614 | Nutrients | French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES. | 2018 | Details |
A13262 | 30060507 | Nutrients | Luteolin-Enriched Artichoke Leaf Extract Alleviates the Metabolic Syndrome in Mice with High-Fat Diet-Induced Obesity. | 2018 | Details |
A13266 | 30060179 | J Clin Endocrinol Metab | Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes. | 2018 | Details |
A13280 | 30052880 | Endocrinology | GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice. | 2018 | Details |
A13281 | 30052309 | Diabetes Metab Res Rev | Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. | 2018 | Details |
A13287 | 30049593 | Surg Obes Relat Dis | In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control. | 2018 | Details |
A13289 | 30049509 | Clin Res Hepatol Gastroenterol | Low urine pH is a risk for non-alcoholic fatty liver disease: A population-based longitudinal study. | 2018 | Details |
A13291 | 30048367 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated? | 2018 | Details |
A13293 | 30047462 | Chin J Nat Med | Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats. | 2018 | Details |
A13297 | 30042872 | Am J Nucl Med Mol Imaging | Hepato-splenic axis: hepatic and splenic metabolic activities are linked. | 2018 | Details |
A13303 | 30041934 | J Pediatr | Assessment of Nonalcoholic Fatty Liver Disease Progression in Children Using Magnetic Resonance Imaging. | 2018 | Details |
A13305 | 30039136 | Food Funct | trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR-451-, and miR-33a-related pathways. | 2018 | Details |
A13307 | 30038487 | Drug Des Devel Ther | Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis. | 2018 | Details |
A13308 | 30038464 | World J Gastroenterol | Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model". | 2018 | Details |
A13311 | 30037123 | Nutrients | Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk. | 2018 | Details |
A13317 | 30034912 | Liver Res | FOXO transcription factors in non-alcoholic fatty liver disease. | 2017 | Details |
A13319 | 30033779 | Expert Rev Gastroenterol Hepatol | Health benefits of Mediterranean diet in nonalcoholic fatty liver disease. | 2018 | Details |
A13322 | 30032465 | Sleep Breath | Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians. | 2018 | Details |
A13325 | 30030460 | Sci Rep | Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD. | 2018 | Details |
A13327 | 30029691 | Cardiovasc Diabetol | Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats. | 2018 | Details |
A13332 | 30027137 | Hepatol Commun | Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes. | 2018 | Details |
A13335 | 30026676 | Food Nutr Res | Bitter melon extract ameliorates palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 cells and high-fat/high-fructose-diet-induced fatty liver. | 2018 | Details |
A13336 | 30026586 | Sci Rep | Substitution of linoleic acid with α-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitis. | 2018 | Details |
A13342 | 30024933 | PLoS One | miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling. | 2018 | Details |
A13346 | 30019598 | Antioxid Redox Signal | Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease? | 2018 | Details |
A13351 | 30018458 | Eur J Clin Nutr | Reappraisal of attenuated insulin sensitivity in the evolution of non-alcoholic fatty liver disease. | 2018 | Details |
A13367 | 30014320 | Hormones (Athens) | Sarcopenic obesity. | 2018 | Details |
A13368 | 30014284 | Biol Trace Elem Res | Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
A13370 | 30013757 | Middle East J Dig Dis | Correlation between Serum Ferritin Level and Histopathological Disease Severity in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
A13372 | 30013137 | Nat Commun | Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis. | 2018 | Details |
A13374 | 30012333 | Gastroenterology | Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases. | 2018 | Details |
A13376 | 30011790 | Int J Mol Sci | New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. | 2018 | Details |
A13380 | 30009716 | Endocr Metab Immune Disord Drug Targets | Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation. | 2019 | Details |
A13383 | 30008738 | PPAR Res | Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice. | 2018 | Details |
A13384 | 30006580 | Int J Obes (Lond) | Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis. | 2018 | Details |
A13387 | 30006154 | Biochim Biophys Acta Mol Basis Dis | GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice. | 2018 | Details |
A13390 | 30005625 | BMC Gastroenterol | Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults. | 2018 | Details |
A13392 | 30002695 | Arch Med Sci | Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease. | 2016 | Details |
A13396 | 30001365 | PLoS One | Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India. | 2018 | Details |
A13409 | 29992039 | Pilot Feasibility Stud | A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease. | 2018 | Details |
A13412 | 29990865 | Biomed Pharmacother | Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway. | 2018 | Details |
A13419 | 29988867 | World J Transplant | Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review. | 2018 | Details |
A13431 | 29976400 | J Food Drug Anal | Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells. | 2018 | Details |
A13435 | 29974828 | Curr Mol Med | The LEPR K109R and Q223R Might Contribute to the Risk of NAFLD: A Meta-Analysis. | 2018 | Details |
A13441 | 29972240 | J Physiol | Maternal obesity has sex-dependent effects on insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring. | 2018 | Details |
A13444 | 29970888 | Nat Rev Gastroenterol Hepatol | Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. | 2018 | Details |
A13447 | 29969922 | Expert Opin Drug Metab Toxicol | Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs. | 2018 | Details |
A13452 | 29965973 | PLoS One | Long-term metabolic effects of malnutrition: Liver steatosis and insulin resistance following early-life protein restriction. | 2018 | Details |
A13462 | 29960159 | Nutrition | Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet-induced obese mice by regulating autophagy. | 2018 | Details |
A13464 | 29959418 | Lab Invest | Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water. | 2018 | Details |
A13466 | 29958960 | J Ethnopharmacol | The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice. | 2018 | Details |
A13468 | 29956790 | Mol Med Rep | Effects of isomaltulose on insulin resistance and metabolites in patients with non‑alcoholic fatty liver disease: A metabolomic analysis. | 2018 | Details |
A13472 | 29956211 | Adv Exp Med Biol | Autophagy, NAFLD and NAFLD-Related HCC. | 2018 | Details |
A13473 | 29956210 | Adv Exp Med Biol | Microbiota, Obesity and NAFLD. | 2018 | Details |
A13474 | 29956209 | Adv Exp Med Biol | The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease. | 2018 | Details |